Molecular Formula | C14H22N6O4S |
Molar Mass | 370.43 |
Density | 1.75±0.1 g/cm3(Predicted) |
Boling Point | 711.4±70.0 °C(Predicted) |
pKa | 13.26±0.70(Predicted) |
Storage Condition | -20℃ |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.7 ml | 13.498 ml | 26.996 ml |
5 mM | 0.54 ml | 2.7 ml | 5.399 ml |
10 mM | 0.27 ml | 1.35 ml | 2.7 ml |
5 mM | 0.054 ml | 0.27 ml | 0.54 ml |
Use | Ticagrelor (Ticagrelor, also known as Ticagrelor) it is a novel and selective small molecule anticoagulant developed by AstraZeneca and the first reversible binding oral P2Y12 adenosine diphosphate receptor antagonist, ADP-induced platelet aggregation has a significant inhibitory effect, can effectively improve the symptoms of patients with acute coronary heart disease. Impurity H is an impurity produced during the preparation of ticagrelor. |